Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2021 | 10-2020 | 07-2020 | 04-2020 | 01-2020 | |
| Sales | 1,615 | 0 | 0 | 250 | 3 |
| Gross Profit | 1,615 | N/A | N/A | 250 | 3 |
| Operating Expenses | 5,578 | 0 | 5,842 | 6,571 | 7,889 |
| Operating Income | -3,963 | N/A | -5,842 | -6,321 | -7,886 |
| Other Income | -14 | 0 | 13 | 48 | 29 |
| Pre-tax Income | -3,977 | 0 | -5,829 | -6,273 | -7,857 |
| Income Tax | N/A | N/A | N/A | 50 | N/A |
| Net Income Continuous | -3,977 | N/A | -5,829 | -6,323 | -7,857 |
| Net Income | $-3,977 | $N/A | $-5,829 | $-6,323 | $-7,857 |
| EPS Basic Total Ops | -4.00 | N/A | -7.20 | -8.00 | -12.00 |
| EPS Basic Continuous Ops | -3.79 | N/A | -7.57 | -8.35 | -12.15 |
| EPS Diluted Total Ops | -4.00 | N/A | -7.20 | -8.00 | -12.00 |
| EPS Diluted Continuous Ops | -3.79 | N/A | -7.57 | -8.35 | -12.15 |
| EBITDA(a) | $-3,509 | $N/A | $-5,346 | $-5,819 | $-7,385 |